‘Inclusive’ Cancer Research: Don’t Reinforce False Perceptions – Medscape

America’s biomedical research establishment is in the midst of a reckoning on racial justice. Having witnessed the devastation of COVID-19 in Black and other minority communities, researchers are being pressed to confront the long-standing inequities that pervade our field.
It is new territory for many, and pitfalls of language and history abound.
ASCO PresidentLori J. Pierce, MD
Low minority enrollment in clinical trials is especially important. In cancer research, only about 5% of trial participants…

Click here to view the original article.